Redmond, WA, United States of America

Randall Schatzman′


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Randall Schatzman

Introduction

Randall Schatzman is a notable inventor based in Redmond, WA (US). He has made significant contributions to the field of biotechnology, particularly in the synthesis of heteromultimeric polypeptides. His innovative work has implications for various applications in protein engineering and therapeutic development.

Latest Patents

Randall Schatzman holds a patent titled "Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy." This patent describes methods for the synthesis and secretion of recombinant hetero-multimeric proteins in mating competent yeast. The process involves transforming a first expression vector into a first haploid cell and a second expression vector into a second haploid cell. The transformed haploid cells, each synthesizing a non-identical polypeptide, are then genetically crossed or fused. The resulting diploid strains are utilized to produce and secrete fully assembled and biologically functional hetero-multimeric proteins. He has 1 patent to his name.

Career Highlights

Throughout his career, Randall has worked with esteemed organizations such as Keck Graduate Institute and Alder Biopharmaceuticals, Inc. His experience in these institutions has allowed him to advance his research and contribute to the field of biotechnology significantly.

Collaborations

Randall has collaborated with notable colleagues, including James M Cregg and John A Latham. These collaborations have further enriched his research and innovation in the field.

Conclusion

Randall Schatzman is a distinguished inventor whose work in synthesizing heteromultimeric polypeptides has made a lasting impact on biotechnology. His innovative methods and collaborations continue to influence the development of new therapeutic proteins.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…